MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-08-0041372
Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2025
₹48.84 Lakh
▲ 76% YoY
Net loss · FY 2025
₹36.29 Lakh
Net margin -74.3%
EBITDA · FY 2025
-₹35.94 Lakh
EBITDA margin -73.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Meddroid Pharmaceutical Private Limited
Data last updated:
Meddroid Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 November 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2022PTC407616.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Meraj Uddin Mir and Naushad Alam.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 194 Basement Lajpat Nagar – 1 Near Park, New Delhi, Delhi, India – 110014.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.84 Lakh, a growth of 76% compared to the previous year. For the same year it recorded a net loss of ₹36.29 Lakh (net margin -74.3%) and EBITDA of -₹35.94 Lakh (EBITDA margin -73.6%).
Meddroid Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0041372). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Meddroid Pharmaceutical Private Limited
CIN U51909DL2022PTC407616
Registration Number 407616
Incorporation Date 30 November 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-08-0041372
Key People
Meraj Uddin Mir Director Naushad Alam Director Recognitions & Rankings of Meddroid Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA – 194 Basement Lajpat Nagar – 1 Near Park, New Delhi, Delhi, India – 110014
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Meddroid Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Meddroid Pharmaceutical Private Limited
The main business activity of Meddroid Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Meddroid Pharmaceutical Private Limited FY 2025 filings available
Meddroid Pharmaceutical Private Limited reported revenue of ₹48.84 Lakh (up 76% YoY) for FY 2025.
Revenue · FY 2025
₹48.84 Lakh ▲ 76%
Net loss · FY 2025
₹36.29 Lakh margin -74.3%
EBITDA · FY 2025
-₹35.94 Lakh margin -73.6%
Compounded Annual Growth Rate (CAGR) of Meddroid Pharmaceutical Private Limited
Revenue CAGR growth
1 year
▲ 76%
Revenue rose 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Meddroid Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹35.94 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹36.29 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Meddroid Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -73.6% | •••• | •••• |
| Net Profit Margin | -74.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Meddroid Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meraj Uddin Mir | Director | 30 Nov 2022 | 3 Years 10 Months | Current |
| Naushad Alam | Director | 18 Mar 2024 | 2 Years 7 Months | Current |
Peer Comparison of Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sandee Medicare Private Limited | ₹49.04 Lakh (FY 2024) | •••• | •••• | -19.0% | •••• | Delhi, India |
| Unisoul Lifescience Private Limited | ₹48.93 Lakh (FY 2024) | •••• | •••• | 83.0% | •••• | Nagpur, Maharashtra, India |
| Zedon Biotech Private Limited | ₹48.9 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Dolamind Pharmaceutical Private Limited | ₹48.9 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Mumbai, Maharashtra, India |
| Amitav Health Care Centre Private Limited | ₹48.9 Lakh (FY 2024) | •••• | •••• | 64.0% | •••• | Tal Jath, Dist Sangli, Maharashtra, India |
| Meddroid Pharmaceutical Private Limited this company | ₹48.84 Lakh (FY 2025) | •••• | •••• | 76.0% | •••• | New Delhi, Delhi, India |
| Styrax Healthcare Private Limited | ₹48.84 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Amritsar, Punjab, India |
| Coxswain Bio Remedies Private Limited | ₹48.81 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Hisar, Haryana, India |
| Inventive Impex Private Limited | ₹48.8 Lakh (FY 2025) | •••• | •••• | 307.0% | •••• | New Delhi, Delhi, India |
| Pragyaa Pharmacy Private Limited | ₹48.79 Lakh (FY 2023) | •••• | •••• | 474.0% | •••• | Jaipur, Rajasthan, India |
| Stargenics India Private Limited | ₹48.77 Lakh (FY 2024) | •••• | •••• | 21.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Meddroid Pharmaceutical by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Meddroid Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Meddroid Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Faisal Samad ceased to be Director on 18 Mar 2024.
AGM
Meddroid Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Meddroid Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Faisal Samad ceased to be Director.
Ceased
Muzafar Ghul ceased to be Director.
Appointed
Naushad Alam was appointed as Director.
Appointed
Meraj Uddin Mir was appointed as Director.
Incorporation
30 Nov 2022
Meddroid Pharmaceutical Private Limited was registered on 30 Nov 2022 with Roc Delhi & aged 3 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Meddroid Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Meddroid Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Meddroid Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Meddroid Pharmaceutical Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Meddroid Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Meddroid Pharmaceutical Private Limited
Meddroid Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 November 2022 (4+ years old) and is registered under CIN U51909DL2022PTC407616.
Meddroid Pharmaceutical reported revenue of ₹48.84 Lakh for FY 2025 (up 76% YoY).
Meddroid Pharmaceutical has 2 current directors:
- Meraj Uddin Mir - Director
- Naushad Alam - Director
Meddroid Pharmaceutical reported a net loss of ₹36.29 Lakh (net margin -74.3%) and EBITDA of -₹35.94 Lakh (EBITDA margin -73.6%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Meddroid Pharmaceutical is U51909DL2022PTC407616. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meddroid Pharmaceutical was incorporated on 30 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Meddroid Pharmaceutical by revenue are Sandee Medicare Private Limited, Unisoul Lifescience Private Limited, Zedon Biotech Private Limited, Dolamind Pharmaceutical Private Limited, Amitav Health Care Centre Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Faisal Samad ceased to be Director on 18 Mar 2024. Muzafar Ghul ceased to be Director on 18 Mar 2024. Naushad Alam was appointed as Director on 18 Mar 2024. Meddroid Pharmaceutical has 4 board changes on record in total.
Yes, Meddroid Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-08-0041372).
The registered office of Meddroid Pharmaceutical is at A – 194 Basement Lajpat Nagar – 1 Near Park, New Delhi, Delhi, India – 110014.
Meddroid Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.